110 related articles for article (PubMed ID: 21778315)
41. Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression.
Yuan W; Collado-Hidalgo A; Yufit T; Taylor M; Varga J
J Cell Physiol; 1998 Oct; 177(1):174-86. PubMed ID: 9731757
[TBL] [Abstract][Full Text] [Related]
42. Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock.
Jung ID; Lee MG; Chang JH; Lee JS; Jeong YI; Lee CM; Park WS; Han J; Seo SK; Lee SY; Park YM
J Immunol; 2009 Mar; 182(5):3146-54. PubMed ID: 19234212
[TBL] [Abstract][Full Text] [Related]
43. Transfection of indoleamine 2,3 dioxygenase in primary endothelial cells.
Mouratidis PX; George AJ
Methods Mol Biol; 2010; 616():149-59. PubMed ID: 20379874
[TBL] [Abstract][Full Text] [Related]
44. The immunoregulatory role of IDO-producing human dendritic cells revisited.
Terness P; Chuang JJ; Opelz G
Trends Immunol; 2006 Feb; 27(2):68-73. PubMed ID: 16406698
[TBL] [Abstract][Full Text] [Related]
45. Marked increases in hippocampal neuron indoleamine 2, 3-dioxygenase via IFN-gamma-independent pathway following transient global ischemia in mouse.
Hoshi M; Saito K; Murakami Y; Taguchi A; Fujigaki H; Tanaka R; Takemura M; Ito H; Hara A; Seishima M
Neurosci Res; 2009 Mar; 63(3):194-8. PubMed ID: 19121343
[TBL] [Abstract][Full Text] [Related]
46. Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: the Health 2000 study.
Niinisalo P; Raitala A; Pertovaara M; Oja SS; Lehtimäki T; Kähönen M; Reunanen A; Jula A; Moilanen L; Kesäniemi YA; Nieminen MS; Hurme M
Scand J Clin Lab Invest; 2008; 68(8):767-70. PubMed ID: 18622801
[TBL] [Abstract][Full Text] [Related]
47. Molecular evidence that melatonin is enzymatically oxidized in a different manner than tryptophan: investigations with both indoleamine 2,3-dioxygenase and myeloperoxidase.
Ferry G; Ubeaud C; Lambert PH; Bertin S; Cogé F; Chomarat P; Delagrange P; Serkiz B; Bouchet JP; Truscott RJ; Boutin JA
Biochem J; 2005 May; 388(Pt 1):205-15. PubMed ID: 15636586
[TBL] [Abstract][Full Text] [Related]
48. Expression of indoleamine 2,3-dioxygenase in carcinoma of human endometrium and uterine cervix.
Sedlmayr P; Semlitsch M; Gebru G; Karpf E; Reich O; Tang T; Wintersteiger R; Takikawa O; Dohr G
Adv Exp Med Biol; 2003; 527():91-5. PubMed ID: 15206720
[TBL] [Abstract][Full Text] [Related]
49. The role of IDO in brain tumor immunotherapy.
Zhai L; Lauing KL; Chang AL; Dey M; Qian J; Cheng Y; Lesniak MS; Wainwright DA
J Neurooncol; 2015 Jul; 123(3):395-403. PubMed ID: 25519303
[TBL] [Abstract][Full Text] [Related]
50. [Progress of researches on the involvement of indoleamine 2, 3-dioxygenase in regulation of parasite-host immune interactions].
Wang LJ; Ma PY; Liu H; Cao JP; Li HM; Zheng MH
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2020 Jul; 33(2):209-212. PubMed ID: 34008371
[TBL] [Abstract][Full Text] [Related]
51. IDO and clinical conditions associated with depressive symptoms.
Kohl C; Sperner-Unterweger B
Curr Drug Metab; 2007 Apr; 8(3):283-7. PubMed ID: 17430116
[TBL] [Abstract][Full Text] [Related]
52. Neuroinflammation and depression: the role of indoleamine 2,3-dioxygenase (IDO) as a molecular pathway.
Sublette ME; Postolache TT
Psychosom Med; 2012 Sep; 74(7):668-72. PubMed ID: 22923699
[No Abstract] [Full Text] [Related]
53. Activity of selected aromatic amino acids in biological systems.
Krzyściak W
Acta Biochim Pol; 2011; 58(4):461-6. PubMed ID: 22175049
[TBL] [Abstract][Full Text] [Related]
54. Beyond immunosuppression: reconsidering indoleamine 2,3-dioxygenase as a pathogenic element of chronic inflammation.
Muller AJ; Mandik-Nayak L; Prendergast GC
Immunotherapy; 2010 May; 2(3):293-7. PubMed ID: 20635895
[No Abstract] [Full Text] [Related]
55. Forty-three key gene expressions involved in the effect of indoleamine 2,3-dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3-dioxygenase 1 inhibitor biomarker.
Li W; Guo L; Xing Z; Fang X; Liang H; Zhang S; Shi L; Kuang C; Shi L; Zheng Y; Hu Y; Yang Q
Clin Transl Med; 2021 Feb; 11(2):e330. PubMed ID: 33634987
[No Abstract] [Full Text] [Related]
56. [IDO, an enzyme that induces dangerously obesity].
Laurans L; Taleb S
Med Sci (Paris); 2018; 34(8-9):660-661. PubMed ID: 30230468
[No Abstract] [Full Text] [Related]
57. Amino acid auxotrophy as a system of immunological control nodes.
Murray PJ
Nat Immunol; 2016 Feb; 17(2):132-9. PubMed ID: 26784254
[TBL] [Abstract][Full Text] [Related]
58. Tryptophan catabolism during intracellular infection.
Schroecksnadel S; Kurz K; Weiss G; Fuchs D
J Infect Dis; 2012 May; 205(10):1617-8; author reply 1618. PubMed ID: 22492858
[No Abstract] [Full Text] [Related]
59. Clinical biomedical research of indoleamine 2,3-dioxygenase: update on current available reports from Southeast Asia.
Joob B; Yasri S; Wiwanitkit V
Int J Biochem Mol Biol; 2021; 12(3):55-59. PubMed ID: 35103109
[TBL] [Abstract][Full Text] [Related]
60. Corrigendum: MicroRNA-153 decreases tryptophan catabolism and inhibits angiogenesis in bladder cancer by targeting indoleamine 2,3-dioxygenase 1.
Zhang W; Mao S; Shi D; Zhang J; Zhang Z; Guo Y; Wu Y; Wang R; Wang L; Huang Y; Yao X
Front Oncol; 2023; 13():1208728. PubMed ID: 37284200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
